ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MA NEWS why is Mastercard Incorporated price falling or rising

MA NEWS reasons for why stock price of Mastercard Incorporated is falling or rising

MA Mastercard Incorporated is falling or rising technical reasons

Technical analysis forecast for Mastercard Incorporated Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Mastercard Incorporated MA at this time. Stock is falling and might fall more.

It appears as if Mastercard Incorporated MA gave a large move recently.

Stock of Mastercard Incorporated (MA) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Mastercard Incorporated is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 493.5 as stoploss in an intra day buy trade for a target of 497.77. However, stock will show a bearish move below 493.5.

MA Mastercard Incorporated is falling or rising NEWS fundamental reasons

Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoY Natco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins and lower annual earnings weighed on investor sentiment despite a one-time tax-related benefit recorded during the quar - NEWS as on 2026-05-29 indiatimes.com

True North buys 25% stake in pharma co Embio Private equity firm True North is investing approximately million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients for regulated markets. This investment will support Embio's research and development and capacity expansion. It will al - NEWS as on 2026-05-27 indiatimes.com

After-Hours Earnings Report for May 26, 2026 : ZS, SMTC, MOD, SQM, BOX, QFIN, TRNS, APPS, OOMA, BBAR, HMR The following companies are expected to report earnings after hours on 05/26/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Zscaler, Inc. (ZS)is reporting for the quarter ending April 30, 2026. The security company's conse - NEWS as on 2026-05-26 nasdaq.com

4 Large-Cap Pharma Stocks to Buy as Industry Recovery Accelerates In the Large-Cap Pharmaceuticals industry, LLY, J&J, NVO and BAYRY are worth retaining as the industry shows some recovery. - NEWS as on 2026-05-26 nasdaq.com

Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue? Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength. These sectors are hitting new highs, driven by struct - NEWS as on 2026-05-25 indiatimes.com

Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividend Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while revenue declined 6% from Rs 15,520 crore reported in the October-December quarter of FY26. - NEWS as on 2026-05-22 indiatimes.com

Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments Bank Benchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to continue its consolidation between 23,200 and 23,900. Several companies, including ITC, LIC, Sun Pharma, Maruti Suzuki - NEWS as on 2026-05-22 indiatimes.com

Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter? Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formulations, and emerging markets. Brokerages highlight US portfolio strength, new launches like Unloxcyt, and a steady ma - NEWS as on 2026-05-21 indiatimes.com

Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead? Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pharma index rebounded from early losses to rise nearly 1%, crossing the 25,000 mark and hitting a fresh 52-week high of - NEWS as on 2026-05-20 indiatimes.com

Diploma H1 Earnings Call Highlights Diploma (LON:DPLM) reported what management described as a “very strong” first half for the six months ended March 31, 2026, with double-digit organic growth, higher margins and upgraded full-year expectations. Chief Executive Officer Johnny T - NEWS as on 2026-05-19 nasdaq.com

Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a month - NEWS as on 2026-05-18 indiatimes.com

Nithin Kamath flags how painful it is for NRIs to invest in India; Ashish Kacholia, Shankar Sharma react Zerodha CEO Nithin Kamath highlighted the challenges NRIs face while investing in India, calling the process unnecessarily difficult despite strong diaspora interest. While Ashish Kacholia supported his concerns over regulatory friction and capital flow hu - NEWS as on 2026-05-15 indiatimes.com

Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked target Cipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despite a weak Q4 performance. The stock hit an intraday high of Rs 1,432.10 as investors focused on future growth prospect - NEWS as on 2026-05-14 indiatimes.com

More announcements and NEWS

MA Mastercard Incorporated current price & indicator signals

Moving Averages for Mastercard Incorporated

  • 5Day Average: 494.86
  • 12Day Average: 496.06
  • 20Day Average: 496.62
  • 50Day Average: 501.36
  • 100Day Average: 515.35
  • 150Day Average: 529.06
  • 200Day Average: 541.88

MA Indicators & signals

Indicator MACD (12,26,9)

496.35, 498.8, -2.43
Indicator MACD is in negative zone

Indicator ADX (14)

0.41, 23.43, 23.63
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MA Mastercard Incorporated are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Fri May 2026 493.98 492.30 to 500.11 0.05% 0.79 times
28 Thu May 2026 493.75 486.35 to 494.58 -0.26% 1.59 times
27 Wed May 2026 495.04 492.51 to 499.35 0.41% 1.15 times
26 Tue May 2026 493.01 492.06 to 496.85 -1.11% 0.79 times
22 Fri May 2026 498.54 497.32 to 504.26 -0.22% 0.79 times
21 Thu May 2026 499.62 490.07 to 501.38 0.25% 1 times
20 Wed May 2026 498.36 490.80 to 500.10 -0.29% 0.89 times
19 Tue May 2026 499.81 498.50 to 512.90 -1.2% 0.6 times
18 Mon May 2026 505.86 490.95 to 506.23 2.36% 0.75 times
15 Fri May 2026 494.20 492.33 to 502.28 0.87% 1.39 times
14 Thu May 2026 489.94 488.01 to 494.50 -0.14% 1.05 times
13 Wed May 2026 490.64 490.32 to 498.60 -1.83% 1.35 times

Videos related to: MA NEWS why is Mastercard Incorporated price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

MA NEWS why is Mastercard Incorporated price falling or rising

 

Back to top